Guided Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.073; its P/E ratio is -1.18; Guided Therapeutics is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 32.00K	$ 44.00K	$ 22.00K	-	$ 3.00K
Gross Profit	$ 16.00K	$ 11.00K	$ 13.00K	$ -79.00K	$ 3.00K
EBIT	$ -314.00K	$ -1.49M	$ -803.00K	$ -1.99M	$ -947.00K
EBITDA	$ -259.00K	$ -1.43M	$ -751.00K	$ -123.00K	$ -929.00K
Net Income Common Stockholders	$ -469.00K	$ -1.60M	$ -969.00K	$ -9.61M	$ -1.05M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 1.36M	$ 1.84M	$ 2.31M	$ 2.70M
Total Assets	$ 1.67M	$ 2.35M	$ 2.89M	$ 3.37M	$ 3.87M
Total Debt	$ 2.06M	$ 2.09M	$ 2.11M	$ 2.18M	$ 2.67M
Net Debt	$ 2.06M	$ 732.00K	$ 274.00K	$ -133.00K	$ -30.00K
Total Liabilities	$ 5.47M	$ 5.66M	$ 5.75M	$ 6.25M	$ 6.52M
Stockholders Equity	$ -6.72M	$ -3.31M	$ -2.85M	$ -2.88M	$ -2.65M
Cash Flow	-
Free Cash Flow	$ -336.00K	$ -438.00K	$ -499.00K	$ -341.00K	$ -609.00K
Operating Cash Flow	$ -336.00K	$ -438.00K	$ -499.00K	$ -338.00K	$ -612.00K
Investing Cash Flow	-	-	-	$ -3.00K	$ 3.00K
Financing Cash Flow	$ 196.00K	$ -41.00K	$ 23.00K	$ -42.00K	$ 2.86M

Currency in USD

Guided Therapeutics Earnings and Revenue History

Income Statement >

Guided Therapeutics Debt to Assets

Balance Sheet >

Guided Therapeutics Cash Flow

Cash Flow >

Guided Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing